The content is available as a PDF (118.3 KB).
. 2009 Jan 7;12:S50. doi: 10.1016/S1201-9712(09)60140-5
OL-043 Mechanism and therapeutic efficacy of peroxisome proliferator activated receptor agonist for virus-associated hemophagocytic syndrome
YL Chen
, WC Hsieh
, BS Lan
, IJ Su
YL Chen
Find articles by YL Chen
WC Hsieh
Find articles by WC Hsieh
BS Lan
Find articles by BS Lan
IJ Su
Find articles by IJ Su
Issue date 2008 Nov.
Copyright © 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7129163